Login / Signup

Correction: Kohsaka et al. Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11 , 5828.

Shun KohsakaSuguru OkamiNaru MoritaToshitaka Yajima
Published in: Journal of clinical medicine (2023)
In the original publication [...].
Keyphrases
  • heart failure
  • angiotensin converting enzyme
  • angiotensin ii
  • cardiac resynchronization therapy